Larvol Delta - Aurora-Kinase-Inhibitor-LY3295668-in-Combination-With-Osimertinib-for-the-Treatment-of-Advanced-or-Metastatic-EGFRMutant-Nonsquamous-Nonsmall-Cell-Lung-Cancer

Tagrisso (osimertinib) - AstraZeneca

LY3295668 - Eli Lilly

http://clinicaltrials.gov/ct2/show/NCT05017025

Sep 19, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next